MetaCap

Metagenomi Therapeutics (MGX) News

NASDAQ: MGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.565-0.0488 (-7.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MGX news summary

We found 4 recent headlines mentioning Metagenomi Therapeutics (MGX): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire. MGX is making an outsized move today, down 7.95% at $0.565, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London", was published by GlobeNewswire on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Metagenomi Therapeutics headlines

Compare MGX